We are live on ! Find out more
GRNA

GreenLight Biosciences Holdings, PBC Common Stock
GRNA

Delisted

GRNA was delisted on the 21st of July, 2023.

Back to rankings

54 hedge funds and large institutions have $134M invested in GreenLight Biosciences Holdings, PBC Common Stock in 2021 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 11 increasing their positions, 3 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,200% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 1

267% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 3

69% more funds holding

Funds holding: 32 → 54 (+22)

40% more capital invested

Capital invested by funds: $95.9M → $134M (+$37.9M)

Holders
54
Holders Change
+22
Holders Change %
+68.75%
% of All Funds
0.94%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
23
Increased
11
Reduced
3
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AC
Aristeia Capital
Connecticut
+$6.29M
2
HCM
Highbridge Capital Management
New York
+$4.53M
3
Alyeska Investment Group
Alyeska Investment Group
Illinois
+$3.41M
4
Bank of Montreal
Bank of Montreal
Ontario, Canada
+$3.4M
5
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
+$3.17M

Top Sellers

Rank Fund Capital Flow
1
UOC
UBS O'Connor
Illinois
-$3.4M
2
TCM
Tuttle Capital Management
Connecticut
-$280K
3
UBS Group
UBS Group
Switzerland
-$51.5K
4
TCM
Tenor Capital Management
New York
-$36.1K
Name Holding Trade Value Shares
Change 		Change in
Stake
CM
51
Cohanzick Management
New York
$19K +$18.5K +1,900 New
MI
52
MMCAP International
Cayman Islands
$1.96K – – –
TRCT
53
Tower Research Capital (TRC)
New York
$1K +$1.28K +131 New
MF
54
Magnetar Financial
Illinois
$106 +$105K +10,820 New
TCM
55
Tuttle Capital Management
Connecticut
– -$280K -28,942 Closed
1 2
3

GRNA Hedge Fund Activity: Q2 2021 in Review

54 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in GreenLight Biosciences Holdings, PBC Common Stock (GRNA) for Q2 2021, worth a combined $134M — up 40% from $95.9M a quarter earlier.

Buyers outnumbered sellers: 23 funds opened new GRNA positions and 1 closed out — a net gain of 22 holders — while 11 added to existing stakes and 3 trimmed.

The largest buyer was Aristeia Capital, opening a new position worth an estimated $6.29M. The largest seller was UBS O'Connor, cutting an estimated $3.4M.

  • 54 institutional investors held GreenLight Biosciences Holdings, PBC Common Stock (GRNA) as of Q2 2021, up from 32 in Q1 2021.
  • Funds reported $134M of GreenLight Biosciences Holdings, PBC Common Stock stock for Q2 2021, up 40% quarter-over-quarter.
  • 23 funds opened new GreenLight Biosciences Holdings, PBC Common Stock positions in Q2 2021 and 1 closed out, a net change of +22 holders.
  • The largest GreenLight Biosciences Holdings, PBC Common Stock buyer in Q2 2021 was Aristeia Capital, an estimated $6.29M added.
  • The largest GreenLight Biosciences Holdings, PBC Common Stock seller in Q2 2021 was UBS O'Connor, an estimated $3.4M sold.

Based on aggregated 13F filings for Q2 2021.